UBS Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-222,712
| Closed | -$4.44M | – | 10602 |
|
|
2022
Q3 | $4.44M | Buy |
222,712
+179,496
| +415% | +$3.58M | ﹤0.01% | 1808 |
|
|
2022
Q2 | $298K | Sell |
43,216
-71,909
| -62% | -$496K | ﹤0.01% | 3678 |
|
|
2022
Q1 | $1.07M | Buy |
115,125
+40,591
| +54% | +$377K | ﹤0.01% | 3171 |
|
|
2021
Q4 | $1.06M | Buy |
74,534
+52,754
| +242% | +$750K | ﹤0.01% | 3401 |
|
|
2021
Q3 | $505K | Buy |
21,780
+13,825
| +174% | +$321K | ﹤0.01% | 3725 |
|
|
2021
Q2 | $198K | Sell |
7,955
-41,886
| -84% | -$1.04M | ﹤0.01% | 4339 |
|
|
2021
Q1 | $1.4M | Buy |
49,841
+48,066
| +2,708% | +$1.35M | ﹤0.01% | 3057 |
|
|
2020
Q4 | $62K | Buy |
1,775
+1,508
| +565% | +$52.7K | ﹤0.01% | 5013 |
|
|
2020
Q3 | $13K | Sell |
267
-170
| -39% | -$8.28K | ﹤0.01% | 5790 |
|
|
2020
Q2 | $20K | Buy |
+437
| New | +$20K | ﹤0.01% | 5730 |
|